{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:47:39Z","timestamp":1790156859357,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.biopha.2017.04.117","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T09:07:17Z","timestamp":1494493637000},"page":"776-787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Adipose-derived mesenchymal stem cells slow disease progression of acute-on-chronic liver failure"],"prefix":"10.1016","volume":"91","author":[{"given":"Carlos","family":"Gilsanz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Angeles","family":"Aller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherezade","family":"Fuentes-Julian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Bl\u00e1zquez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Argudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Fern\u00e1ndez-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Bele\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda P.","family":"De Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.04.117_bib0005","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2017.04.117_bib0010","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.jhep.2014.11.045","article-title":"Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis","volume":"62","author":"Arroyo","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2017.04.117_bib0015","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/TP.0b013e31822e6eda","article-title":"Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes","volume":"92","author":"Bahirwani","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.biopha.2017.04.117_bib0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.gastro.2014.05.005","article-title":"Toward an improved definition of acute-on-chronic liver failure","volume":"147","author":"Jalan","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2017.04.117_bib0025","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/17474124.2015.967761","article-title":"Biliary complications after liver transplantation","volume":"9","author":"Nemes","year":"2015","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2017.04.117_bib0030","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1002\/stem.1818","article-title":"Concise review: therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis","volume":"32","author":"Volarevic","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.biopha.2017.04.117_bib0035","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/liv.12134","article-title":"Liver tissue engineering and cell sources: issues and challenges","volume":"33","author":"Palakkan","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2017.04.117_bib0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3727\/096368911X605286b","article-title":"Regenerative cells for transplantation in hepatic failure","volume":"21","author":"Ishikawa","year":"2012","journal-title":"Cell Transpl."},{"key":"10.1016\/j.biopha.2017.04.117_bib0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.TP.0000128326.95294.14","article-title":"Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice","volume":"78","author":"Fang","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.biopha.2017.04.117_bib0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1440-1746.2008.05496.x","article-title":"Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure","volume":"24","author":"Banas","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2017.04.117_bib0055","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1172\/JCI43267","article-title":"Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice","volume":"120","author":"Espejel","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2017.04.117_bib0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.stemcr.2015.04.017","article-title":"Amelioration of hyperbilirubinemia in gunn rats after transplantation of human induced pluripotent stem cell-derived hepatocytes","volume":"5","author":"Chen","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.biopha.2017.04.117_bib0065","first-page":"459","article-title":"Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis","volume":"10","author":"Mohamadnejad","year":"2007","journal-title":"Arch Iran Med."},{"key":"10.1016\/j.biopha.2017.04.117_bib0070","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/MEG.0b013e32832a1f6c","article-title":"Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I\u2013II clinical trial","volume":"21","author":"Kharaziha","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2017.04.117_bib0075","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/hep.24434","article-title":"Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes","volume":"54","author":"Peng","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2017.04.117_bib0080","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/MEG.0b013e3283488b00","article-title":"Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells","volume":"23","author":"Amer","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2017.04.117_bib0085","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s12015-011-9322-y","article-title":"Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis","volume":"8","author":"El-Ansary","year":"2012","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.biopha.2017.04.117_bib0090","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/ctr.12179","article-title":"Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study","volume":"27","author":"Amin","year":"2013","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.biopha.2017.04.117_bib0095","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/liv.12228","article-title":"Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis","volume":"33","author":"Mohamadnejad","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2017.04.117_bib0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/gut.2006.111617","article-title":"Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential","volume":"57","author":"di Bonzo","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2017.04.117_bib0105","doi-asserted-by":"crossref","first-page":"e6657","DOI":"10.1371\/journal.pone.0006657","article-title":"Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver","volume":"4","author":"Baertschiger","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biopha.2017.04.117_bib0110","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.scr.2013.08.011","article-title":"Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence?","volume":"11","author":"Meier","year":"2013","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.biopha.2017.04.117_bib0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/00365529309096038","article-title":"A model of cholestasis in the rat, using a microsurgical technique","volume":"28","author":"Aller","year":"1993","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2017.04.117_bib0120","series-title":"Microsurgery in Liver Research","first-page":"137","article-title":"Extrahepatic cholestasis","author":"Aller","year":"2009"},{"key":"10.1016\/j.biopha.2017.04.117_bib0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/107632701300062859","article-title":"Multilineage cells from human adipose tissue: implications for cell-based therapies","volume":"7","author":"Zuk","year":"2001","journal-title":"Tissue Eng."},{"key":"10.1016\/j.biopha.2017.04.117_bib0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.biopha.2017.04.117_bib0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.diff.2014.02.007","article-title":"c-Kit identifies a subpopulation of mesenchymal stem cells in adipose tissue with higher telomerase expression and differentiation potential","volume":"87","author":"Blazquez-Martinez","year":"2014","journal-title":"Differentiation"},{"key":"10.1016\/j.biopha.2017.04.117_bib0140","doi-asserted-by":"crossref","first-page":"e0117945","DOI":"10.1371\/journal.pone.0117945","article-title":"Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome","volume":"10","author":"Fuentes-Julian","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biopha.2017.04.117_bib0145","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbrc.2004.12.158","article-title":"Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo","volume":"328","author":"Seo","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2017.04.117_bib0150","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jhep.2004.02.010","article-title":"Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease","volume":"40","author":"Said","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2017.04.117_bib0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1742-4682-4-44","article-title":"Inflammation: a way to understanding the evolution of portal hypertension","volume":"4","author":"Aller","year":"2007","journal-title":"Theor. Biol. Med. Model."},{"key":"10.1016\/j.biopha.2017.04.117_bib0160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40139-014-0057-8","article-title":"Strategies to detect hepatic myofibroblasts in liver cirrhosis of different etiologies","volume":"2","author":"Iwaisako","year":"2014","journal-title":"Curr. Pathobiol. Rep."},{"key":"10.1016\/j.biopha.2017.04.117_bib0165","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2014.08.021","article-title":"Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats","volume":"742","author":"Mahmoud","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.04.117_bib0170","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1755-1536-1-6","article-title":"Experimental obstructive cholestasis: the wound-like inflammatory liver response","volume":"1","author":"Aller","year":"2008","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.biopha.2017.04.117_bib0175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jss.2009.06.010","article-title":"Splanchnic Th(2) and Th(1) cytokine redistribution in microsurgical cholestatic rats","volume":"162","author":"Garcia-Dominguez","year":"2010","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.biopha.2017.04.117_bib0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11894-016-0535-8","article-title":"Acute-on chronic liver failure","volume":"12","author":"Sarin","year":"2016","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.biopha.2017.04.117_bib0185","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1053\/j.gastro.2008.03.015","article-title":"Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells","volume":"134","author":"Kuo","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2017.04.117_bib0190","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1478-3231.2008.01855.x","article-title":"Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo","volume":"29","author":"Yan","year":"2009","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2017.04.117_bib0195","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/j.gastro.2009.05.044","article-title":"Stem cells and liver regeneration","volume":"137","author":"Duncan","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2017.04.117_bib0200","doi-asserted-by":"crossref","first-page":"e941","DOI":"10.1371\/journal.pone.0000941","article-title":"Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure","volume":"2","author":"Parekkadan","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biopha.2017.04.117_bib0205","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00441-006-0334-x","article-title":"Administration of fibroblast growth factor 2 in combination with bone marrow transplantation synergistically improves carbon-tetrachloride-induced liver fibrosis in mice","volume":"327","author":"Ishikawa","year":"2007","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.biopha.2017.04.117_bib0210","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00441-012-1524-3","article-title":"Effects of transplanted bone-marrow-derived mesenchymal stem cells in animal models of acute hepatitis","volume":"351","author":"Zhu","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.biopha.2017.04.117_bib0215","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/lt.22083","article-title":"Prospects for stem cell transplantation in the treatment of hepatic disease","volume":"16","author":"Stutchfield","year":"2010","journal-title":"Liver Transpl."},{"key":"10.1016\/j.biopha.2017.04.117_bib0220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/liv.12218","article-title":"Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study","volume":"34","author":"Jang","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2017.04.117_bib0225","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/gut.2008.154880","article-title":"Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo","volume":"58","author":"Aurich","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2017.04.117_bib0230","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1111\/j.1440-1746.2006.04708.x","article-title":"Participation of bone marrow cells in biliary fibrosis after bile duct ligation","volume":"22","author":"Asawa","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2017.04.117_bib0235","first-page":"189","article-title":"Cell therapy in chronic liver disease","volume":"32","author":"Nicolas","year":"2016","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.biopha.2017.04.117_bib0240","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.3727\/096368912X652959","article-title":"Adipose-derived stem cells can abrogate chemical-induced liver fibrosis and facilitate recovery of liver function","volume":"21","author":"Harn","year":"2012","journal-title":"Cell Transpl."},{"key":"10.1016\/j.biopha.2017.04.117_bib0245","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2007.05.150","article-title":"Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells","volume":"363","author":"Parekkadan","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2017.04.117_bib0250","first-page":"831","article-title":"Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury","volume":"6","author":"Xagorari","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.biopha.2017.04.117_bib0255","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.gastro.2014.05.001","article-title":"The portal fibroblast: not just a poor man's stellate cell","volume":"147","author":"Wells","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2017.04.117_bib0260","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2017.04.117_bib0265","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cgh.2013.01.005","article-title":"Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies","volume":"11","author":"Rockey","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2017.04.117_bib0270","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13287-016-0320-5","article-title":"The hepatocyte growth factor-expressing character is required for mesenchymal stem cells to protect the lung injured by lipopolysaccharide in vivo","volume":"7","author":"Hu","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biopha.2017.04.117_bib0275","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/cr.2010.44","article-title":"Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair","volume":"20","author":"Shi","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2017.04.117_bib0280","doi-asserted-by":"crossref","first-page":"26605","DOI":"10.1074\/jbc.M100740200","article-title":"Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL","volume":"276","author":"Kovalovich","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.04.117_bib0285","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2004.11.043","article-title":"Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression","volume":"42","author":"Bansal","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2017.04.117_bib0290","doi-asserted-by":"crossref","first-page":"816","DOI":"10.5966\/sctm.2015-0191","article-title":"Hypoxic conditioned medium from human adipose-derived stem cells promotes mouse liver regeneration through JAK\/STAT3 signaling","volume":"5","author":"Lee","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.biopha.2017.04.117_bib0295","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2174\/156652412800619950","article-title":"Immunosuppressive properties of mesenchymal stem cells: advances and applications","volume":"12","author":"De Miguel","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.biopha.2017.04.117_bib0300","doi-asserted-by":"crossref","first-page":"e38973","DOI":"10.5812\/hepatmon.38973","article-title":"Serum C-reactive protein in children with liver disease and ascites","volume":"16","author":"Kalvandi","year":"2016","journal-title":"Hepat. Mon."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216327640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216327640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:16:59Z","timestamp":1760095019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216327640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":60,"alternative-id":["S0753332216327640"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.04.117","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adipose-derived mesenchymal stem cells slow disease progression of acute-on-chronic liver failure","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.04.117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}